company-logoEvolus, Inc.$6.23
%
Analyst Rating: Hold

Stock Details

CEO

David Moatazedi

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Full Time Employees

372

Address

520 Newport Center Drive, Newport Beach, CA, 92660

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Top Competitors

Income Statement  

Financials

Selected Year

Revenue Estimates

EPS Estimates

Net Income Estimates

Price target for Evolus, Inc.  $6.23

EPS

Revenue

Institutional Holder

Congress Tracker 

Insider Trading of Key Employees

Financial News: EOLS